About Truveta
Truveta is a Healthcare company based in Seattle (United States) founded in 2020 by Terry Myerson. Healthcare data platform for learning services is provided. Truveta has raised $515 million across 4 funding rounds from investors including Microsoft, Illumina and Regeneron Pharmaceuticals. The company has 474 employees. Truveta was last valued at $1 billion in December 2025. Its chief executive, as recorded, is Terry Myerson. Its website truveta.com draws about 27 thousand monthly visits. Truveta offers products and services including Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include Carta Healthcare, Flywheel and Verana Health; 3 of its 3 listed competitors have raised funding.
Company details
Truveta was founded in 2020 and is headquartered in Seattle, United States. Operations are focused on the healthcare sector, where a data platform is utilized for learning services. Real-world data from various health systems is aggregated and analyzed to support research and insights. The platform enables secure access to de-identified patient information for collaborative studies. Leadership is provided by CEO Terry Myerson, with emphasis placed on advancing evidence-based healthcare decisions.
- Total Equity Funding$515M (USD)
in 4 rounds
- Latest Funding Round$320M (USD), Series C
Jan 2025
- InvestorsMicrosoft
& 10 more
- Employee Count474
Products & Services of Truveta
Truveta offers a comprehensive portfolio of products and services, including Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions.
Provides EHR data for research and analytics purposes.
Analyzes clinical notes and images for health insights.
Facilitates collaboration on health data studies and trials.
Supports drug discovery through genotypic and phenotypic data.
Apps and channels of Truveta
its YouTube channel Truveta has 336 subscribers and 30 videos.
Videos from Truveta
The most watched videos on Truveta's YouTube channel, Truveta (336 subscribers). Click a video to play it here.
More on Truveta.
Funding Insights of Truveta
Truveta has successfully raised a total of $515M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $320 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $515M
- Total Rounds 4
- Last Round Series C — $320M
- First Round $95M
(Jul 2021)
- Investors Count 11
All 4 funding rounds of Truveta with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $320M | Series C | – | – | |
| Nov 2021 | $100M | Series B | – | – | – |
| Sep 2021 | Series A | – | – | ||
| Jul 2021 | $95M | Series A | – | – |
| Date | Valuation | Stage |
|---|
Full valuation and stage history of Truveta
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $1B (Dec 2025). 11 investors in total: 11 institutional.
Investors in Truveta
Truveta has secured backing from 11 investors, including institutional investors. Prominent investors backing the company include Microsoft, Illumina and Regeneron Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Antibodies are developed for treating cancer, eye, and inflammatory diseases. | 1988 | regeneron.com | Tarrytown, United States | |
Trinity Health is recognized for providing healthcare and community services. | 2013 | trinity-health.org | Livonia, United States | |
A chain of multispecialty hospitals is operated in New York. | 1997 | northwell.edu | New York, United States | |
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States | |
Healthcare transformation, workforce, and related services are provided. | 2019 | commonspirit.org | Chicago, United States | |
Chain of multispeciality hospitals | 1859 | providence.org | United States | |
Healthcare services are delivered by a not-for-profit system. | 1897 | advocatehealth.com | Oak Brook, United States | |
Healthcare services are delivered nationwide through integrated medical facilities. | 1915 | henryford.com | United States | |
Microsoft is recognized for software, hardware, and gaming solutions. | 1975 | microsoft.com | Redmond, United States | |
Advocate Health is recognized as a leading nonprofit health system. | advocateaurorahealth.org | Charlotte, United States |
Investor details for Truveta
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Truveta
126 people are tracked at Truveta (57 in leadership, 12 in board & advisors, 57 in team); the tracked headcount is 474.
| Name | Role | Group |
|---|---|---|
Terry Myerson | Co-Founder & CEO | Leadership |
Kelly Qu | Senior Director Of Product Marketing | Leadership |
Adi Unnithan | VP Of Engineering | Leadership |
Kyle Fennelly | Director Of Partner Growth - Life Sciences And Emerging Biotech | Leadership |
Sebastien Leger | Sr. Director, Marketing Strategy & Operations | Leadership |
Jay Nanduri | CTO & Co-Founder | Leadership |
Ryan Ahern | CMO & Co-Founder | Leadership |
Fabien Mousseau | CFO | Leadership |
Colin Penitsch | Financial Planning And Analysis Business Partner | Leadership |
Jeffrey E. Graff | SVP & Chief Corporate Development Officer | Leadership |
Moses Yap | VP Of Engineering | Leadership |
Jefferey Chen | Director Of Engineering - Genomics | Leadership |
Ben Kallman | Director Of Product Management | Leadership |
Eugene Shinn | Director Of Engineering | Leadership |
Abdolkarim Dabbagh | Director Of Engineering | Leadership |
Vijeta Khatri | Director Of Engineering | Leadership |
Ram Sunkara | Director Of Engineering | Leadership |
Patty C. | Director Of Engineering | Leadership |
Sanjay Mahida | Director Of Engineering | Leadership |
Angela Winegar | VP Of Health System Engagement | Leadership |
106 more people are available in the full profile.
Complete people profiles for Truveta
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Truveta
4 dated milestones of Truveta across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Truveta is founded.
- Funding First funding round of $95.0M.
- Funding Latest funding round, Series C, of $320.0M.
- Milestone Reaches Unicorn status.
Competitors of Truveta
Truveta has 3 listed competitors in our database, 3 of them funded. They include Carta Healthcare, Flywheel and Verana Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| carta.healthcare | 2017 | San Mateo, United States | $80.55M | 57 | AI-driven clinical data management tools are offered to healthcare providers. | |
| flywheel.io | 2015 | Minneapolis, United States | $123.86M | Cloud-based platform for healthcare data capture and analysis is offered. | ||
| veranahealth.com | 2011 | San Francisco, United States | $287.8M | Verana Health is focused on real-world data analytics in healthcare. |
Detailed competitors of Truveta
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Truveta
The website of Truveta (truveta.com) receives about 27.2K visits a month.
- Monthly visits27.2K
▲ 7.8% vs previous month
Websites whose visitors overlap most with Truveta. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aetion.com | 100% | 7.4K | #2,906,332 | View details | |
| atroposhealth.com | 96% | 18.8K | #1,202,452 | View details | |
| cdc.gov | 94% | 16.4M | #4,309 | View details | |
becarispublishing.com | becarispublishing.com | 67% | #353,693 | – | |
| precisionformedicine.com | 60% | 36.8K | #1,000,701 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Truveta
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Truveta (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Truveta
Complete news archive for Truveta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Truveta
Truveta was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Truveta is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Terry Myerson is the CEO of Truveta, as recorded in our data. They have also founded this company.
Truveta is a funded company, having raised a total of $515M across 4 funding rounds to date. The company's 1st funding round was a Series A of $95M, raised on Jul 2021.
Truveta has 474 employees.
Truveta was founded in 2020 and is headquartered in Seattle, United States. Operations are focused on the healthcare sector, where a data platform is utilized for learning services. Real-world data from various health systems is aggregated and analyzed to support research and insights. The platform enables secure access to de-identified patient information for collaborative studies. Leadership is provided by CEO Terry Myerson, with emphasis placed on advancing evidence-based healthcare decisions.
Truveta's top competitors include Carta Healthcare, Verana Health and Flywheel.
Truveta offers Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions.
Truveta has 11 investors. Key investors include Microsoft, Illumina, Regeneron Pharmaceuticals, Providence Health & Services, and Northwell.
The valuation of Truveta is $1B as of Dec 2025.